Abstract
Oral metoprolol, in a dose sufficient to reduce resting pulse rate by 25%, was compared with repeated injection sclerotherapy for the long term management of variceal bleeding. The prospective, randomised study was undertaken in 32 patients with biopsy proven cirrhosis and variceal bleeding who were Grade A or B on a modified Child's classification. In the 15 patients receiving metoprolol, portal pressure showed a mean fall of 3.7 mmHg (17.3 +/- 1.2 to 13.6 +/- 1.2 mmHg, p less than 0.01) after four weeks of continuous therapy, as compared with pretreatment levels. Nine of the 15 patients taking metoprolol had further bleeding (total of 21 episodes) compared with six of 17 in the sclerotherapy group (nine episodes). The risk of bleeding per patient/month of follow up was three times higher in the metoprolol group compared with those treated by sclerotherapy (0.14 and 0.04 respectively, p less than 0.025). Rebleeding in the metoprolol group occurred in six of the patients who had a fall in portal pressure of 10% or more.
Full text
PDFSelected References
These references are in PubMed. This may not be the complete list of references from this article.
- Burroughs A. K., Jenkins W. J., Sherlock S., Dunk A., Walt R. P., Osuafor T. O., Mackie S., Dick R. Controlled trial of propranolol for the prevention of recurrent variceal hemorrhage in patients with cirrhosis. N Engl J Med. 1983 Dec 22;309(25):1539–1542. doi: 10.1056/NEJM198312223092502. [DOI] [PubMed] [Google Scholar]
- Hillon P., Lebrec D., Muńoz C., Jungers M., Goldfarb G., Benhamou J. P. Comparison of the effects of a cardioselective and a nonselective beta-blocker on portal hypertension in patients with cirrhosis. Hepatology. 1982 Sep-Oct;2(5):528–531. doi: 10.1002/hep.1840020503. [DOI] [PubMed] [Google Scholar]
- Lebrec D., De Fleury P., Rueff B., Nahum H., Benhamou J. P. Portal hypertension, size of esophageal varices, and risk of gastrointestinal bleeding in alcoholic cirrhosis. Gastroenterology. 1980 Dec;79(6):1139–1144. [PubMed] [Google Scholar]
- Lebrec D., Nouel O., Corbic M., Benhamou J. P. Propranolol--a medical treatment for portal hypertension? Lancet. 1980 Jul 26;2(8187):180–182. doi: 10.1016/s0140-6736(80)90063-x. [DOI] [PubMed] [Google Scholar]
- Lebrec D., Poynard T., Hillon P., Benhamou J. P. Propranolol for prevention of recurrent gastrointestinal bleeding in patients with cirrhosis: a controlled study. N Engl J Med. 1981 Dec 3;305(23):1371–1374. doi: 10.1056/NEJM198112033052302. [DOI] [PubMed] [Google Scholar]
- MacDougall B. R., Westaby D., Theodossi A., Dawson J. L., Williams R. Increased long-term survival in variceal haemorrhage using injection sclerotherapy. Results of a controlled trial. Lancet. 1982 Jan 16;1(8264):124–127. doi: 10.1016/s0140-6736(82)90378-6. [DOI] [PubMed] [Google Scholar]
- Pugh R. N., Murray-Lyon I. M., Dawson J. L., Pietroni M. C., Williams R. Transection of the oesophagus for bleeding oesophageal varices. Br J Surg. 1973 Aug;60(8):646–649. doi: 10.1002/bjs.1800600817. [DOI] [PubMed] [Google Scholar]
- REYNOLDS T. B., REDEKER A. G., GELLER H. M. Wedged hepatic venous pressure; a clinical evaluation. Am J Med. 1957 Mar;22(3):341–350. doi: 10.1016/0002-9343(57)90090-6. [DOI] [PubMed] [Google Scholar]
- Westaby D., Bihari D. J., Gimson A. E., Crossley I. R., Williams R. Selective and non-selective beta receptor blockade in the reduction of portal pressure in patients with cirrhosis and portal hypertension. Gut. 1984 Feb;25(2):121–124. doi: 10.1136/gut.25.2.121. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Westaby D., Macdougall B. R., Melia W., Theodossi A., Williams R. A prospective randomized study of two sclerotherapy techniques for esophageal varices. Hepatology. 1983 Sep-Oct;3(5):681–684. doi: 10.1002/hep.1840030509. [DOI] [PubMed] [Google Scholar]
- Wilkinson R. P. Propranolol and portal hypertension in cirrhosis. Lancet. 1980 Aug 23;2(8191):429–429. doi: 10.1016/s0140-6736(80)90480-8. [DOI] [PubMed] [Google Scholar]
- Williams K. G., Dawson J. L. Fibreoptic injection of oesophageal varices. Br Med J. 1979 Sep 29;2(6193):766–767. doi: 10.1136/bmj.2.6193.766. [DOI] [PMC free article] [PubMed] [Google Scholar]